BIIB FY 2014 Earnings — Biogen Inc. Revenue & Financial Results | Market Cap Arena

BIIBBiogen Inc.

$28B

FY 2014 Earnings

Healthcare Drug Manufacturers - General

Income Statement

Revenue

$9.7B+40.0% YoY

Gross Profit

$8.5B87.9% margin

Operating Income

$4.0B40.9% margin

Net Income

$2.9B30.2% margin

EPS (Diluted)

$12.37

Cash Flow

Operating Cash Flow

$2.9B

Free Cash Flow

$2.6B

Stock-Based Comp.

$155M

Balance Sheet

Total Assets

$14.3B

Total Liabilities

$3.5B

Stockholders' Equity

$10.8B

Cash & Equivalents

$1.2B

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$9.7B	$6.9B	+40.0%
Gross Profit	$8.5B	$6.1B	+40.5%
Operating Income	$4.0B	$2.5B	+57.9%
Net Income	$2.9B	$1.9B	+57.6%